Common Reward Pathway

download Common Reward Pathway

of 7

Transcript of Common Reward Pathway

  • 7/30/2019 Common Reward Pathway

    1/7

    Stellenbosch University Shaun Shelly|076-511-0863

    [email protected]

    Addictions Care Course 1 Page 1 of 7

    The common reward pathway for substances of abuse,

    specifically relating to neuroanatomy and

    neurophysiology.

    Shaun Shelly

    Although substances of abuse have varied and diverse primary targets and acute

    effects neurochemically, research has shown that almost all substances of abuse lead

    to an increase in dopamine in the mesocorticolimbic dopaminergic system. The

    understanding of this common reward pathway is important as it could (i) lead to the

    development of a single medication that works for various classes of substances of

    abuse in addiction treatment; and (ii) give a better understanding as to why all those

    suffering from addiction experience similar psycho-social devastation in spite of the

    variety of drugs of choice.

    The Reward System

    As humans we are prepared to allocate time, effort and energy in the acquisition of the

    things that are essential for our survival. These things can be considered the fruit,

    or reward, of our labour.

    The human brain has a complex system of reward that has evolved to assist in the

    mediation of pleasurable behaviour (Esch & Stefano, 2004). Primary reward is

    designed to ensure human survival by directing us toward beneficial behaviours such

    as eating and procreating and then reinforcing such essential behaviours (Goldstein,

    2002) (Nestler E. , 2005) (World Health Organisation, 2004). Secondary reward deals

    with more abstract concepts such as achieving life goals (Taber, Black, Porrino, &Hurley, 2012).

    Box 1:

    Brief description of main areas involved in the reward system

    Ventral

    Tegmental Area

    (VTA)

    The VTA is situated in the evolutionary old area called the

    midbrain. It consists of a group of neurons and is the origin

    of the dopaminergic cell bodies. Although there are relatively

    few neurons (about 5000) these dopaminergic neurons can

    have an axonal length of 74cm and 500,000 terminals per

    individual neuron. As a result the dopaminergic neuronshave an extensive reach to multiple areas and modulate

    diverse brain functions (Arias-Carrion et al, 2010).

  • 7/30/2019 Common Reward Pathway

    2/7

    Stellenbosch University

    Addictions Care

    At the centre of the reward

    (World Health Organisation,

    projects from the ventral t

    prefrontal cortex and is t

    mesolimbic pathway links th

    Nucleus

    Accumbens

    (NAc)

    The N

    consist

    these c

    neural

    amino

    the N

    neuron

    striato-

    Limbic System The li

    linepart of

    closely

    the link

    the Ma

    Prefrontal

    Cortex

    (PFC)

    This is

    cortex

    ability

    predict

    other t

    Shaun Shelly|07

    shaun.shelly

    Course 1

    system are the mesolimbic and mesocortical

    2004) (Esch & Stefano, 2004). The mesocorti

    egmental area (VTA) to the perirhinal, cin

    ought to be important for reward proce

    VTA with the limbic system via the nucleus

    FMRi Image Source: Princeton University

    c forms the main portion of the ventral striat

    of two bodies, one for each hemisphere, and

    onsists of two structures, the core and the sh

    cells produce the neurotransmitter

    utyric acid (GABA), and these neurons proje

    c. Projecting into the NAc are the dopa

    s from the VTA. The VTA is a part of the

    thalamo-cortical loop.

    CMRi Image Source: Wikimedia

    bic system consists of the set of brain structu

    he cortex. In some literature the NAc is conthe limbic system. The areas of the limbic

    linked to reward are the Amygdala and, bec

    between memory and reward, the Hippocam

    mmillary body.

    the anterior part of the frontal lobes. The pr

    is primarily credited with executive functi

    to make decisions, determine good fro

    ion of consequences, salience and inhibition a

    ings.

    6-511-0863

    yahoo.com

    a e 2 of 7

    pathways

    c pathway

    ulate and

    ssing. The

    ccumbens

    m and

    each of

    ell. The

    amma-

    t from

    inergic

    ortico-

    es that

    sideredsystem

    use of

    us and

    frontal

    n: the

    bad,

    mongst

  • 7/30/2019 Common Reward Pathway

    3/7

    Stellenbosch University

    Addictions Care

    (NAcc) and is thought to be i

    Porrino, & Hurley, 2012). See

    In response to a motivationa

    excited and they send an elec

    This causes dopamine to be r

    on the NAcc neurons. The a

    slight mood elevation to eu

    response in the case recurrin

    It is important in terms of adstages is the actual receipt of

    to the reward that triggers t

    relevant event. Should the

    result in further dopamine re

    process.

    Shaun Shelly|07

    shaun.shelly

    Course 1

    mportant for the reinforcement of reward (Ta

    Figure 1

    lly relevant event, the VTA is stimulated. Ner

    tronic impulse along the axons that project int

    eleased into the synapse and then latches ont

    ctivation of this system produces changes ra

    phoria. In this way we develop an adaptive

    events or stimuli (Kalivas & Volkow, 2005).

    diction that the motivationally relevant eventhe reward, while after time it is the repeate

    he release of dopamine and acts as the mo

    reward exceed the anticipated level of rewar

    lease and even further enhance the learning a

    6-511-0863

    yahoo.com

    a e 3 of 7

    ber, Black,

    e cells are

    the NAcc.

    receptors

    ging from

    behaviour

    t in initialprecursor

    ivationally

    d, this can

    nd reward

  • 7/30/2019 Common Reward Pathway

    4/7

    Stellenbosch University Shaun Shelly|076-511-0863

    [email protected]

    Addictions Care Course 1 Page 4 of 7

    It is believed that it is this reward system, along with the serotonin systems, that is co-

    opted and eventually modified by substances of abuse (Dackis & C, 2005).

    Box 2:

    The discovery and evidence of the reward system

    During the 1950s a number of experiments were conducted by stimulating

    various brain areas in a variety of rats (Olds & Milner, 1954). It was discovered

    that by stimulating the various areas the rats would seek to repeat the

    experience through self-stimulation, even to the point of physical exhaustion

    and in spite of physical discomfort.

    In further animal experiments, if dopamine was blocked they stopped

    partaking in rewarding activities (Wise, 1998). Paradoxically the elimination of

    dopamine does not seem to affect the ability to like certain things, such as

    sweetness. (Pecina et al,1997). This would imply that other systems are

    involved in the wanting of things, as per Koob, 1992.

    In a series of very controversial experiments during the 1960s Heath inserted

    an electrode into the NAc of patient B-19. He then continuously self-

    stimulated even though he was left frustrated and had a nervous feeling

    (Heath, 1964).

    These, and further experiments, have certainly strengthened the case for the

    existence of a reward pathway as described in this essay. It is, however,

    unfortunate that this has sometimes been erroneously labelled the pleasure

    centre or pathway, which has had some unfortunate implications in the

    understanding of the development of addiction in those that use substances

    of abuse.

    The effects of substances of abuse

    When a substance of abuse is administered it starts a cascade of complex reactions in

    the brain. The chemistry of substances of abuse is as diverse as there are names, and

    each one has a specific protein target in the brain.

    As discussed, dopamine is central to the reward system and forms the basis of all

    current models of instrumental responding. Therefore, if there is a common reward

    pathway for substances of abuse, it would seem logical that all these substances of

    abuse would have an effect on dopamine.

    If we consider the varied acute effects of the multitude of substances of abuse the

    likelihood of a common reward pathway may seem remote, however, if we examine

    the actions of many of these substances we find this to be the case. The following table

    gives a simplified overview:

  • 7/30/2019 Common Reward Pathway

    5/7

    Stellenbosch University Shaun Shelly|076-511-0863

    [email protected]

    Addictions Care Course 1 Page 5 of 7

    Substance PMA Main Effect Other

    Cocaine Blocks DA uptake Inc Dopamine Directly increase

    doperminergic

    transmission in the

    NAcLSD Inc Serotonin

    Heroin Activates Mu &

    delta receptors

    Inc Dopamine through

    disinhibition in the VTA

    of dopamine neurons

    and direct effects on DA

    terminals

    Amphetamines Inc Dopamine &

    blocks DA uptake

    Inc Dopamine

    Nicotine Acetylcholine Inc Dopamine

    Alcohol GABA &

    Substance P

    Inc GABA Increased MDP

    activityMarijuana Activates

    Endocannabinoid

    receptors

    Inc Dopamine in

    MDP

    MDMA Inc Serotonin

    and block 5-HT

    uptake

    Inc Serotonin Inc Dopamine

    I have highlighted the instances where dopamine release is stimulated, and indeed we

    see that the substances of abuse listed here all seem to have an effect on dopamine

    levels, which will in turn activate the natural reward pathway. This evidence is further

    enhanced by the observation that substances of abuse can lead to cross-tolerance andcross-sensatization (Nestler E. , 2005).

    Having said this and pointed out the importance of the dopaminergic pathways and

    the increased levels of dopamine during drug administration, there is evidence that the

    reward system may collapse under the constant artificial stimulation by drugs of choice

    and natural dopamine levels may drop significantly causing a variety of negative

    affective states (Esch & Stefano, 2004) (Nestler E. , 2005). It is at this point that other

    systems take over.

    Conclusion

    While all the current evidence seems to demonstrate that there is indeed a commonreward pathway, its not the only place that substances of abuse are active, and it is

    doubtful that the effects on the reward pathway are identical. It also seems that while

    this reward pathway is responsible for the development of addiction, the chronic state

    of addiction probably lies in other systems.

    The value in understanding the common reward pathway for substances of abuse and

    natural rewards is not so that we can block that reward pathway this would raise

  • 7/30/2019 Common Reward Pathway

    6/7

    Stellenbosch University Shaun Shelly|076-511-0863

    [email protected]

    Addictions Care Course 1 Page 6 of 7

    serious bio-ethical issues but rather so we can prevent the hi-jacking and

    modification of this system that moves an individual from the state of being a

    substance user or activity partaker to being addicted to it.

    Further research in this direction would possibly lead to the development of a

    medication that could be used to treat all compulsions and addictive behaviours,

    natural or substance induced, possibly developing an addiction vaccine. The big

    question is: if such a vaccine were to be developed, who would want to take it?

    BIBLIOGRAPHY

    Alexander, B., & Schweighofer, R. (1988). Defining "Addiction". Canadian Psychology,

    29(2):151-162.

    Arias-Carrion, O., Stamelou, M., Murillo-Rodriguez, E., & et al. (2010). Dopaminergic

    reward system: a short integrative review. International Archives of Medicine , 3(24):.

    Berridge, C., & Kringelbach, M. (2011). Building a neuroscience of pleasure and well-

    being. Psychology of Well-Being: Theory Reasearch and Practice , 1(3):.Dackis, C., & C, O. (2005). Neurobiology of addiction: treatment and public policy

    ramifications. Nature Neuroscience , 8(11) 1431-1436.

    E, T., & Stefano, G. (2005). The neurobiology of love. Neuroendocrinology Letters ,

    3(26):176-192.

    Esch, T., & Stefano, G. (2004). The neurobiology of pleasure, reward processes,

    addiction and their health implications. Neuroendocrinology Letters , 25(4):235-251.

    Goldstein, R. V. (2002). Drug addiction and its underlying neurobiological basis:

    Neuroimaging evidence for the involvement of the frontal cortex.American Journal of

    Psychiatry, 159(10): 1642-1652.

    Horn, G. e. (2008). Brain science, addiction and drugs. London: The Academy of

    Medical Sciences.Kreek, M., Nielson, D., Butelman, E., & LaForge, K. (2005). Genetic influences on

    impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and

    addiction. Nat Neurosci, 8: 1450-7.

    Laviolette, S., & van der Kooy, D. (2004). The neurobiology of nicotine addiction:

    Bridging the gap from molecules to behaviour. Nature Reviews , (5) 55-65.

    Lingford-Hughes, A., & Nutt, D. (2003). Neurobiology of addiction and implications for

    treatment. British Jurnal of Psychiatry, (182) 97-100 .

    Nestler. (1992). Molecular Mechanisms of Drug Addiction. The Journal of Neuroscience

    , 12 (7): 2439-2450.

    Nestler, E. (2005). Is there a common molecular pathway for addiction? Nature

    Neuroscience , 8(11)1445-1449.(2004). Neuroscience of psychoactive substance use and dependence. Geneva: World

    Health Organization.

    Olds, J., & Milner, P. (1954). Positive reinforcement produced by electrical stimulation

    of the septal area and other regions of rat brain. Journal of Comparative and

    Physiological Psychology, 47:419-427.

    Robinson, T., & K, B. (2000). The psychology and neurobiology of addiction: an

    incentive-sensitization view.Addiction , (95) 91-117.

  • 7/30/2019 Common Reward Pathway

    7/7

    Stellenbosch University Shaun Shelly|076-511-0863

    [email protected]

    Addictions Care Course 1 Page 7 of 7

    Taber, K., Black, D., Porrino, L., & Hurley, R. (2012). Neuroanatomy of dopamine:

    Reward and Addiction.Journal of Neuropsychiatry Clinical Neuroscience .

    Volkow, N., Baler, R., & Goldstein, R. (2011). Addiction: Pulling at the Neural Threads of

    Social Behaviours. Neuron , 69: 599-602.

    West, R. (2005). Theory of Addiction. Blackwell Publishing: Oxford.

    World Health Organisation. (2004). Neuroscience of psychoactive substance use and

    dependence. Geneva: World Health Organisation.